Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAN-WAR-D - Danish Warfarin-Dialysis Study
2022-502500-75-00Phase 4Authorised
- Sponsor
- Rigshospitalet
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of warfarin in Atrial fibrillation (AFib) and end-stage kidney disease (ESKD) (2 arms), sponsored by Rigshospitalet. Planned start Jan 2023; status: authorised.
02
Drugs
warfarin
03
Conditions
Atrial fibrillation (AFib)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2022-502500-75-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502500-75-00.